Redefine What’s Possible
Moonshots succeed when bold ideas are guided by thoughtful strategy and disciplined execution.
Innovating at the edge of technology isn’t easy. Redefining life science takes more.
Luna LifeSci helps pioneers turn ambition into impact.
Navigating the Future of Preclinical Drug Development
Animal studies can only take us so far, while organ-on-a-chip, organoid, and microphysiological systems platforms are unlocking human biology with unprecedented accuracy. Human-relevant models are redefining drug development, and the leaders will be those who act now. Position your company at the forefront of this transformation.
*Image from Watanabe, et al. Stem Cell Reports, 2022
For Life Science Startups & Founders
Forging a company at the nexus of translational science and transformative innovation requires clarity of vision and bold leadership. We have navigated the journey from first experiment to global pharma partnerships. With proven experience, we provide the strategic, hands-on guidance to scale breakthroughs into industry-leading companies.
*Image from Ota et al, Analytical Science, 2019.
J. Lowry Curley, PhD
Where Innovation Meets Strategy in Life Science.
Founded by J. Lowry Curley, PhD, Luna LifeSci Advising guides pharma and biotech companies leveraging human-relevant technologies and supports startups building scalable businesses from breakthrough science.
Lowry is a scientist-entrepreneur who has spent the last 15 years pushing the frontiers of human neurobiology by building next-gen platforms that combine 3D neural tissue engineering, embedded bioelectronics, and AI-driven analytics to transform how we model, understand, and repair the brain. As the founder and CEO of AxoSim (now 28bio), he led the development and launch of the industry-leading Brain-on-a-Chip and Nerve-on-a-Chip platforms, working with 20 of the world’s top 25 pharmaceutical companies.
Under Lowry's leadership, AxoSim grew from a university spinout to a recognized innovation engine in neurobiology, neurotechnology, and neural interfacing. He spearheaded product strategy across multiple technology domains, directing IP licensing from Johns Hopkins, University of California San Diego, and Tulane University and guiding M&A activity to expand AxoSim’s footprint and portfolio. Along the way, Lowry authored 6 patents, more than 20 publications, and 100+ commercial and scientific presentations.
Publications & News
Let’s Innovate Together
For those bold enough to pursue a moonshot, We are here to make the path faster, clearer, and more successful.